Literature DB >> 2974754

Effect of maternal insulin deficiency on vitamin D metabolite concentrations in normoglycemic pregnant rats and their fetuses.

C Rebut-Bonneton1, J Demignon.   

Abstract

The effect on vitamin D metabolite concentrations of insulin deficiency, not accompanied by hyperglycemia, were investigated in pregnant rats and in their fetuses injected with 75 mg/kg BW streptozotocin (SZ). These concentrations were measured in maternal plasma and whole fetal body. In the insulinopenic mothers, the 25OHD concentration was found to rise compared with that of control pregnant rats (7.00 +/- 1.66 ng/ml, n = 16, versus control 4.50 +/- 1.60, n = 10, 0.001 less than P less than 0.01). The concentration of 1,25(OH)2D, which was previously found to decrease in pregnant rats that were both hypoinsulinic and hyperglycemic, was previously found to decrease in pregnant rats that were both hypoinsulinic and hyperglycemic, was not different in our control and insulinopenic rats (107.36 +/- 38.25 pg/ml, n = 11, versus control 122.90 +/- 18.20, n = 18.20, n = 8). In fetuses from our SZ-injected rats, the 24,25(OH)2D level diminished compared with the control level (2.12 +/- 0.70 ng/g, n = 11, versus control 5.23 +/- 0.95 ng/g, n = 13, P less than 0.001). The Ca/P ratio in fetal body also decreased (0.68 versus control 1.12). It is suggested that the placental metabolism is an important determinant or normal fetal growth.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974754     DOI: 10.1007/bf02555143

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  18 in total

1.  Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1 alpha-hydroxylase activity.

Authors:  E M Spencer; M Khalil; O Tobiassen
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

2.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol.

Authors:  J G Haddad; K J Chyu
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

3.  Factors affecting the secretion of insulin and glucagon by the rat fetus.

Authors:  J R Girard; A Kervran; E Soufflet; R Assan
Journal:  Diabetes       Date:  1974-04       Impact factor: 9.461

4.  Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy.

Authors:  S Hough; L V Avioli; M A Bergfeld; M D Fallon; E Slatopolsky; S L Teitelbaum
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

5.  24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation.

Authors:  A Ornoy; D Goodwin; D Noff; S Edelstein
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

6.  The effects of subdiabetogenic streptozotocin doses on rat beta cell volume and functions.

Authors:  S Lucke; B Ziegler; K Weidlich; U Barowski; W Besch; H J Hahn
Journal:  Biomed Biochim Acta       Date:  1985

Review 7.  Insulin receptors and the molecular mechanism of insulin action.

Authors:  C R Kahn; M Crettaz
Journal:  Diabetes Metab Rev       Date:  1985

8.  Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat.

Authors:  L E Schneider; H P Schedl; T McCain; M R Haussler
Journal:  Science       Date:  1977-06-24       Impact factor: 47.728

9.  Mineral homeostasis in neonates of streptozotocin-induced noninsulin-dependent diabetic rats and in their mothers during pregnancy and lactation.

Authors:  J Levy; J R Gavin; M J Scott; L V Avioli
Journal:  Bone       Date:  1987       Impact factor: 4.398

10.  Calcium intake regulates 1,25-dihydroxy-vitamin D formation in the diabetic rat.

Authors:  H D Wilson; R L Horst; H P Schedl
Journal:  Diabetes       Date:  1982-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.